BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30819235)

  • 1. The RNA binding protein RBMS3 inhibits the metastasis of breast cancer by regulating Twist1 expression.
    Zhu L; Xi PW; Li XX; Sun X; Zhou WB; Xia TS; Shi L; Hu Y; Ding Q; Wei JF
    J Exp Clin Cancer Res; 2019 Feb; 38(1):105. PubMed ID: 30819235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RBMS3 Inhibits the Proliferation and Metastasis of Breast Cancer Cells.
    Yang Y; Quan L; Ling Y
    Oncol Res; 2018 Jan; 26(1):9-15. PubMed ID: 28409548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1.
    Li LZ; Zhang CZ; Liu LL; Yi C; Lu SX; Zhou X; Zhang ZJ; Peng YH; Yang YZ; Yun JP
    Carcinogenesis; 2014 Feb; 35(2):469-78. PubMed ID: 24085799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression.
    Xu Y; Qin L; Sun T; Wu H; He T; Yang Z; Mo Q; Liao L; Xu J
    Oncogene; 2017 Feb; 36(8):1157-1166. PubMed ID: 27524420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymoquinone inhibits cancer metastasis by downregulating TWIST1 expression to reduce epithelial to mesenchymal transition.
    Khan MA; Tania M; Wei C; Mei Z; Fu S; Cheng J; Xu J; Fu J
    Oncotarget; 2015 Aug; 6(23):19580-91. PubMed ID: 26023736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA binding protein RBMS3 is a common EMT effector that modulates triple-negative breast cancer progression via stabilizing PRRX1 mRNA.
    Block CJ; Mitchell AV; Wu L; Glassbrook J; Craig D; Chen W; Dyson G; DeGracia D; Polin L; Ratnam M; Gibson H; Wu G
    Oncogene; 2021 Nov; 40(46):6430-6442. PubMed ID: 34608266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion.
    Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J
    Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamoxifen inhibits ER-negative breast cancer cell invasion and metastasis by accelerating Twist1 degradation.
    Ma G; He J; Yu Y; Xu Y; Yu X; Martinez J; Lonard DM; Xu J
    Int J Biol Sci; 2015; 11(5):618-28. PubMed ID: 25892968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of TGF-β1 Pathway by SCUBE3 Regulates TWIST1 Expression and Promotes Breast Cancer Progression.
    Yang X; Hu J; Shi C; Dai J
    Cancer Biother Radiopharm; 2020 Mar; 35(2):120-128. PubMed ID: 31742430
    [No Abstract]   [Full Text] [Related]  

  • 10. Aminopeptidase A initiates tumorigenesis and enhances tumor cell stemness via TWIST1 upregulation in colorectal cancer.
    Chuang HY; Jiang JK; Yang MH; Wang HW; Li MC; Tsai CY; Jhang YY; Huang JC
    Oncotarget; 2017 Mar; 8(13):21266-21280. PubMed ID: 28177885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
    Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
    J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tripartite motif containing 28 (TRIM28) promotes breast cancer metastasis by stabilizing TWIST1 protein.
    Wei C; Cheng J; Zhou B; Zhu L; Khan MA; He T; Zhou S; He J; Lu X; Chen H; Zhang D; Zhao Y; Fu J
    Sci Rep; 2016 Jul; 6():29822. PubMed ID: 27412325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivation of TWIST1 contributes to Ewing sarcoma metastasis.
    Choo S; Wang P; Newbury R; Roberts W; Yang J
    Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28873262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-Parvin promotes breast cancer progression and metastasis through interaction with G3BP2 and regulation of TWIST1 signaling.
    Sun Y; Ding Y; Guo C; Liu C; Ma P; Ma S; Wang Z; Liu J; Qian T; Ma L; Deng Y; Wu C
    Oncogene; 2019 Jun; 38(24):4856-4874. PubMed ID: 30804457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-326 regulates EMT and metastasis of endometrial cancer through targeting TWIST1.
    Liu W; Zhang B; Xu N; Wang MJ; Liu Q
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3787-3793. PubMed ID: 28975990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor Suppressor Effect of RBMS3 in Breast Cancer.
    Wang C; Wu Y; Liu Y; Pan F; Zeng H; Li X; Yu L
    Technol Cancer Res Treat; 2021; 20():15330338211004921. PubMed ID: 33910421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down regulation of RNA binding motif, single-stranded interacting protein 3, along with up regulation of nuclear HIF1A correlates with poor prognosis in patients with gastric cancer.
    Wu Y; Yun D; Zhao Y; Wang Y; Sun R; Yan Q; Zhang S; Lu M; Zhang Z; Lu D; Li Y
    Oncotarget; 2017 Jan; 8(1):1262-1277. PubMed ID: 27902480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of CMTM3 promotes metastasis of gastric cancer via the STAT3/Twist1/EMT signaling pathway.
    Yuan W; Li T; Mo X; Wang X; Liu B; Wang W; Su Y; Xu L; Han W
    Oncotarget; 2016 May; 7(20):29507-19. PubMed ID: 27121055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-15a-3p and miR-16-1-3p Negatively Regulate Twist1 to Repress Gastric Cancer Cell Invasion and Metastasis.
    Wang T; Hou J; Li Z; Zheng Z; Wei J; Song D; Hu T; Wu Q; Yang JY; Cai JC
    Int J Biol Sci; 2017; 13(1):122-134. PubMed ID: 28123352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of PCOLCE by TWIST1 promotes metastasis in Osteosarcoma.
    Wang S; Zhong L; Li Y; Xiao D; Zhang R; Liao D; Lv D; Wang X; Wang J; Xie X; Chen J; Wu Y; Kang T
    Theranostics; 2019; 9(15):4342-4353. PubMed ID: 31285765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.